Eurocastle Investment: A Quick 2% Arbitrage Opportunity
Taking my blog in a new direction
I haven’t been blogging much recently. While I like writing, the amount of time and effort it takes to present a bolted shut 5000 words investment case puts me off from doing it as often… Read more
Realm Therapeutics: A Cash Grab In Progress
Summary
Realm Therapeutics has, pending shareholder approval, agreed to be acquired by ESSA Pharma. ESSA’s unattractive bid is in illiquid stock and strongly undervalues Realm’s cash position. Realm’s board and large shareholders clearly have a… Read moreEco Science Solutions: It’s All Just A Little Bit Of History Repeating
Summary
Thanks to a small float and an ongoing stock promotion Eco Science Solutions has been up over 700% over the last twelve months. Today, however, the size of its float has exploded overnight as… Read moreCannabis Sativa: All Hype
Summary
Marijuana stocks have been on fire these last few weeks in anticipation of Tuesday’s marijuana vote; Cannabis Sativa is up 800% this year and now has over a 100M market cap; However, the company… Read moreMGT Capital: Dilution Ahead
MGTSummary
Last Friday MGT Capital filed its long awaited proxy statement with details on the proposed appointment of John McAfee as its new CEO. Proposals with regards to recent acquisitions as well as a stock… Read moreParagon Shipping: Why Its Share Price Spiked, And Why It Will Fall
Comments Off on Paragon Shipping: Why Its Share Price Spiked, And Why It Will Fall
Summary
Shares in shipper PRGN rallied over 500% in the last seven trading days. However, the company recently sold all of its assets to pay down debt and has very little cash left. Even PRGN’s… Read moreEleven Biotherapeutics: No Immediate Pipeline And Running Out Of Cash; 70% Downside.
Comments Off on Eleven Biotherapeutics: No Immediate Pipeline And Running Out Of Cash; 70% Downside.
Summary
EBIO’s main drug failed two Phase 3 studies in a row. However, last month its share price rose 300% on speculation the drug might work after all. Yesterday EBIO squashed these rumors confirming the… Read moreDARA Biosciences: An Attractive Short Term Merger Play
Comments Off on DARA Biosciences: An Attractive Short Term Merger Play
Summary
DARA is planning to be acquired by UK-listed Midatech Pharma. Midatech’s offer to DARA shareholders consists of ADRs as well as a CVR based on certain milestones. After the deal is completed Midatech’s ADRs… Read moreKaloBios: Martin Shkreli Vs. The Rest Of The World
Comments Off on KaloBios: Martin Shkreli Vs. The Rest Of The World